Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia

<b><i>Introduction:</i></b> The prognosis of acute lymphoblastic leukemia (ALL) in adolescents and adults is poor, and recurrence is an important cause of their death. Changes of genetic information play a vital role in the pathogenesis and recurrence of ALL; however, the impact of molecular genetic mutations on disease diagnosis and prognosis remains unexplored. This study aimed to explore the frequency spectrum of gene mutations and their prognostic significance, along with the minimal residual disease (MRD) level and hematopoietic stem cell transplantation (HSCT), in adolescent and adult patients aged ≥15 years with ALL. <b><i>Methods:</i></b> The basic characteristics, cytogenetics, molecular genetics, MRD level, treatment regimen, and survival outcome of patients with untreated ALL (≥15 years) were collected, and the correlation and survival analysis were performed using the SPSS 25.0 and R software. <b><i>Results:</i></b> This study included 404 patients, of which 147 were selected for next-generation sequencing (NGS). NGS results revealed that 91.2% of the patients had at least one mutation, and 67.35% had multiple (≥2) mutations. <i>NOTCH1</i>, <i>PHF6</i>, <i>RUNX1</i>, <i>PTEN</i>, <i>JAK3</i>, <i>TET2</i>, and <i>JAK1</i> were the most common mutations in T-ALL, whereas <i>FAT1</i>, <i>TET2</i>, <i>NARS</i>, <i>KMT2D</i>, <i>FLT3</i>, and <i>RELN</i> were the most common mutations in B-ALL. Correlation analysis revealed the mutation patterns, which were significantly different between T-ALL and B-ALL. In the prognostic analysis of 107 patients with B-ALL, multivariate analysis showed that the number of mutations ≥5 was an independent risk factor for overall survival and the <i>RELN</i> mutation was an independent poor prognostic factor for event-free survival. <b><i>Discussion:</i></b> The distribution of gene mutations and the co-occurrence and repulsion of mutant genes in patients with ALL were closely related to the immunophenotype of the patients. The number of mutations ≥5 and the <i>RELN</i> mutation were significantly associated with poor prognosis in adolescent and adult patients with ALL.